Prucalopride Succinate Tablet
Product Images NDC 70069-821

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride Succinate (NDC 70069-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 01)

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 02)

This information is about a medication called Prucalopride in tablet form. The usual dose is one tablet once daily. Each tablet contains Prucaloprid 1.32 mg (equivalent to 1.32 mg of prucalopride succinate). The medication should be kept out of the reach of children and stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is recommended to store the tablets in the original container to protect them from moisture. The manufacturer of the tablet is Somerset Therapeutics located in Somerset, NJ.*

FDA Label Image

Image (Ee246af0 B06a 45e2 8efa 704918359d36 03)

This text provides information about Prucalopride tablets, with each tablet containing 2 mg of Prucalopride (equivalent to 2.64 mg of prucalopride succinate). The usual dose is one tablet once daily. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets should be kept out of the reach of children and stored in the original container to protect from moisture. The manufacturer is Somerset Therapeutics, LLC. The package contains 30 tablets with a GTIN code of 00370069822012.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.